Irhythm Technologies Inc. (0A7L)
LSE
Closed
Aug 24, 2026
Day's Range
126.1152 wk Range
97.71Overview - 0A7L - Irhythm Technologies Inc.
Key Statistics
Valuation
Enterprise Value
4.31B
Price / Book
‪22.48‬
EV / EBITDA
‪244.12‬
Profitability
Profit Margin
‪-1.69%‬
Operating Margin
‪7.93%‬
Return on Assets
‪0.64%‬
Return on Equity
‪-9.63%‬
Ownership
Float
30.30M
Held by Insiders
‪1.16%‬
Held by Institutions
‪110.72%‬
Price stats
Beta
‪1.32‬
50-Day Avg
‪113.04‬
200-Day Avg
‪102.17‬
Peers - 0A7L - Irhythm Technologies Inc.
Peer Comparison
Compared with companies in Medical Devices listed on LSE.
- 0A7LLSEIrhythm Technologies Inc.-19.00%52-week change—P/E (Trailing)‪-3.52%‬Profit Margin
- ECORLSEEcora Royalties PLC+56.85%52-week change23.43P/E (Trailing)‪39.68%‬Profit Margin
- AOTILSEAoti Inc.+58.63%52-week change135.00P/E (Trailing)‪4.00%‬Profit Margin
- CFXLSEColefax Group PLC+45.49%52-week change11.80P/E (Trailing)‪6.13%‬Profit Margin
- 0K5ELSEDrägerwerk AG & Co. KGaA - Preferred Stock+38.93%52-week change51.10P/E (Trailing)‪1.25%‬Profit Margin
- 0HKDLSEAxogen Inc.+70.81%52-week change—P/E (Trailing)‪-13.21%‬Profit Margin
- SINTLSELeverage Shares IncomeShares Intel (INTC) Options ETP+95.85%52-week change—P/E (Trailing)—Profit Margin
Profile Summary - 0A7L - Irhythm Technologies Inc.
About
iRhythm Technologies Inc. is a leading digital healthcare company that develops and commercializes wearable biosensors and cloud-based analytics for detecting, predicting, and preventing cardiac diseases. Its flagship Zio platform features an FDA-cleared, CE-marked, wire-free patch-based biosensor that records up to…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
